Standard BioTools Financial Overview
Standard BioTools's market cap is currently $626.84M. The company's EPS TTM is $-0.09; its P/E ratio is -4.82; Standard BioTools is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.05. See an overview of income statement, balance sheet, and cash flow financials.
